ロード中...
Oral levosimendan in amyotrophic lateral sclerosis: a phase II multicentre, randomised, double-blind, placebo-controlled trial
OBJECTIVE: To evaluate the efficacy and safety of oral levosimendan in patients with amyotrophic lateral sclerosis (ALS). This phase II, randomised, double-blind, placebo-controlled, crossover, three-period study with 6 months open-label follow-up enrolled adults with ALS and sitting slow vital capa...
保存先:
| 出版年: | J Neurol Neurosurg Psychiatry |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6817985/ https://ncbi.nlm.nih.gov/pubmed/31315908 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp-2018-320288 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|